JAGSNPHARM Intraday Analysis...

JAGSNPHARM Share Price

Open 46.90 Change Price %
High 47.40 1 Day -1.35 -2.88
Low 45.25 1 Week -3.35 -6.85
Close 45.55 1 Month 7.85 20.82
Volume 39815 1 Year 10.50 29.96
52 Week High 50.85
52 Week Low 25.80
JAGSNPHARM Important Levels
Resistance 2 47.54
Resistance 1 46.72
Pivot 46.07
Support 1 44.38
Support 2 43.56
NSE INDIA Most Active Stocks
FEDERALBNK 107.60 14.04%
IFCI 31.70 8.93%
SOUTHBANK 25.70 4.47%
ADANIENT 108.95 -4.56%
JPASSOCIAT 13.65 0.74%
IBREALEST 149.85 -4.13%
SUZLON 20.60 0.49%
JINDALSTEL 114.00 0.22%
IDFCBANK 65.75 0.84%
GMRINFRA 17.25 -1.71%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.20 33.33%
VISESHINFO 0.20 33.33%
AUSTRAL 0.30 20.00%
DHUNINV 244.50 20.00%
TFL 13.85 19.91%
TTML 8.25 19.57%
AMTEKAUTO 39.30 18.37%
FEDERALBNK 107.60 14.04%
CASTEXTECH 8.85 13.46%
FACT 52.80 10.58%
More..
NSE INDIA Top Losers Stocks
GAL 10.05 -19.92%
GAL 10.05 -19.92%
GAL 10.05 -19.92%
SRGINFOTEC 0.30 -14.29%
SHARONBIO 6.45 -10.42%
MVL 0.45 -10.00%
MVL 0.45 -10.00%
SHILPI 119.50 -9.98%
RKDL 13.20 -9.90%
SUPPETRO 391.85 -8.63%
More..

Jagsonpal Pharmaceuticals Limited (NSE: JAGSNPHARM)

JAGSNPHARM Technical Analysis 4
As on 28th Apr 2017 JAGSNPHARM Share Price closed @ 45.55 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 38.08 & Buy for SHORT-TERM with Stoploss of 40.30 we also expect STOCK to react on Following IMPORTANT LEVELS.
JAGSNPHARM Target for April
1st Target up-side 42.31
2nd Target up-side 45.32
3rd Target up-side 48.34
1st Target down-side 33.69
2nd Target down-side 30.68
3rd Target down-side 27.66
Jagsonpal Pharmaceuticals Limited ( NSE INDIA Symbol : JAGSNPHARM )
Sector : Pharmaceuticals - Formulations And Other Stocks in Same Sector
JAGSNPHARM
45.55 -1.35 (-2.88 %)
LT : Strong Buy
ST : Buy
AMRUTANJAN
699.95 0.55 (0.08 %)
LT : Strong Buy
ST : Strong Buy
JAGSNPHARM Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 59.01 Sideways
MFI (14) MFI is 77.02 Sideways
CCI (20) CCI is 67.04 Sideways
WILLIAM %R (14) William %R is -41.73 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 43.62
10 Day Avg Volume Traded -69.09 % Less then 10 Day Average Volume
JAGSNPHARM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals - Formulations
Industry
Offical website
JAGSNPHARM Address
JAGSNPHARM
N/A
Interactive Technical Analysis Chart Jagsonpal Pharmaceuticals Limited ( JAGSNPHARM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Jagsonpal Pharmaceuticals Limited
JAGSNPHARM Business Profile
Jagson Pharma is in the Pharmaceuticals - Formulations sector. Jagsonpal Pharmaceuticals (JAGSONPH) is a pharmaceutical company producing drugs and formulations. The company was incorporated in 1978 as a private limited company and went public in 1986. The company specializes in developing and manufacturing bulk drugs and pharmaceutical formulations. It focuses on several therapeutic groups like anti-arthritics, anti-inflammatories, analgesics, anti-spasmodics, progesterones, anabolic steroids, anesthetics and anti-fungals. Top selling brands include Lycored, Maintane, Metadec, Metabol, Doxypal DR, Parvon, and Indocap SR. The company manufactures active pharmaceutical ingredients (APIs) like Allylestrenol, Disulfiram, Tolnaftate, ..etc. The bulk drug range includes dextropropoxyphene HCl, tolnaftate, dextropropoxyphene napsylate and thiopental sodium. The manufacturing facility in Delhi is WHO and GMP-certified for the production of various dosage forms and bulk drugs and intermediates. The company also maintains a number of dedicated contract manufacturing facilities around the globe. It has an expanding international portfolio of affiliates, joint ventures and representative offices across the globe. The distribution network in India is comprised of over 1,500 authorized stockists who are serviced by depots. The products are retailed at over 125,000 pharmacies. The company is represented by 2,500 agents worldwide and has offices in three continents. The company`s operations span Russia, USA, Brazil, Ukraine, Sri Lanka, Cameroon, Argentina, Thailand, Germany, Switzerland, Korea, Egypt and Vietnam. The company has a sales office in New York through which it services North and Latin American clients and in Belarus, it has an operation center with a sales and distribution team. The current market capitalisation stands at Rs 23.71 crore.The company has reported a standalone sales of Rs 36.79 crore and a Net Profit of Rs 0.01 crore for the quarter ended Sep 2013. The company management includes R P S Kochhar - Chairman & Managing Director, S K Goyal - Director, Govind Deo - Additional Director, Bharat Sinh - Additional Director, Ishpal Singh Ghai - Additional Director. It is listed on the BSE with a BSE Code of 507789 and the NSE with an NSE Code of JAGSNPHARM. Its Registered office is at T-210 J, Shahpur Jat , New Delhi,Delhi - 110049.